 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Marina Halts Majority of Operations Under Cash Crunch
June 07, 2012
Marina Halts Majority of Operations Under Cash Crunch
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Marina Defaults on Loan as Bankruptcy Looms
January 31, 2013 / Gene Silencing News - Marina Extends Cash Runway to Year End, Sells Off Equipment
December 13, 2012 / Gene Silencing News - Debiopharm Drops Out of Bladder Cancer Deal with Cash-Strapped Marina
November 15, 2012 / Gene Silencing News - Marina Says Cash Will Run out at the End of the Month, Reports 2011 Financials
October 18, 2012 / Gene Silencing News - Ag-Bio Firms Increasingly Look to RNAi, microRNAs through Partnerships
May 24, 2012 / Gene Silencing News